Annual CAPEX
$899.80 K
-$586.00 K-39.44%
31 December 2023
Summary:
Molecular Partners AG annual capital expenditures is currently $899.80 thousand, with the most recent change of -$586.00 thousand (-39.44%) on 31 December 2023. During the last 3 years, it has fallen by -$895.30 thousand (-49.87%). MOLN annual CAPEX is now -52.04% below its all-time high of $1.88 million, reached on 31 December 2019.MOLN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$315.00 K
+$102.20 K+48.03%
01 September 2024
Summary:
Molecular Partners AG quarterly capital expenditures is currently $315.00 thousand, with the most recent change of +$102.20 thousand (+48.03%) on 01 September 2024. Over the past year, it has increased by +$131.60 thousand (+71.76%). MOLN quarterly CAPEX is now -52.97% below its all-time high of $669.80 thousand, reached on 31 December 2022.MOLN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$1.01 M
+$131.60 K+14.92%
01 September 2024
Summary:
Molecular Partners AG TTM capital expenditures is currently $1.01 million, with the most recent change of +$131.60 thousand (+14.92%) on 01 September 2024. Over the past year, it has dropped by -$220.10 thousand (-17.84%). MOLN TTM CAPEX is now -39.11% below its all-time high of $1.66 million, reached on 31 March 2022.MOLN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOLN CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.4% | +71.8% | -17.8% |
| 3 y3 years | -49.9% | -30.2% | +1.4% |
| 5 y5 years | +1.5% | - | - |
MOLN CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -49.9% | at low | -53.0% | +118.8% | -39.1% | +15.6% |
| 5 y | 5 years | -52.0% | +1.5% | -53.0% | +118.8% | -39.1% | +473.0% |
| alltime | all time | -52.0% | +77.3% | -53.0% | +118.8% | -39.1% | +473.0% |
Molecular Partners AG CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $315.00 K(+48.0%) | $1.01 M(+14.9%) |
| June 2024 | - | $212.80 K(+42.0%) | $882.00 K(+0.6%) |
| Mar 2024 | - | $149.90 K(-55.4%) | $876.90 K(-2.5%) |
| Dec 2023 | $899.80 K(-39.4%) | $335.90 K(+83.2%) | $899.80 K(-27.1%) |
| Sept 2023 | - | $183.40 K(-11.7%) | $1.23 M(-5.9%) |
| June 2023 | - | $207.70 K(+20.2%) | $1.31 M(+5.1%) |
| Mar 2023 | - | $172.80 K(-74.2%) | $1.25 M(-16.1%) |
| Dec 2022 | $1.49 M(+3.9%) | $669.80 K(+157.1%) | $1.49 M(+19.2%) |
| Sept 2022 | - | $260.50 K(+80.9%) | $1.25 M(-13.3%) |
| June 2022 | - | $144.00 K(-65.0%) | $1.44 M(-13.7%) |
| Mar 2022 | - | $411.40 K(-4.3%) | $1.66 M(+16.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.43 M(-20.3%) | $430.10 K(-4.6%) | $1.43 M(+43.0%) |
| Sept 2021 | - | $451.00 K(+21.2%) | $1.00 M(+82.1%) |
| June 2021 | - | $372.10 K(+110.3%) | $549.00 K(+210.3%) |
| Mar 2021 | - | $176.90 K | $176.90 K |
| Dec 2020 | $1.80 M(-4.3%) | - | - |
| Dec 2019 | $1.88 M(+111.7%) | - | - |
| Dec 2018 | $886.30 K(+74.6%) | - | - |
| Dec 2017 | $507.60 K(-54.4%) | - | - |
| Dec 2016 | $1.11 M(-22.7%) | - | - |
| Dec 2015 | $1.44 M(+141.2%) | - | - |
| Dec 2014 | $597.60 K(-62.4%) | - | - |
| Dec 2013 | $1.59 M | - | - |
FAQ
- What is Molecular Partners AG annual capital expenditures?
- What is the all time high annual CAPEX for Molecular Partners AG?
- What is Molecular Partners AG annual CAPEX year-on-year change?
- What is Molecular Partners AG quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Molecular Partners AG?
- What is Molecular Partners AG quarterly CAPEX year-on-year change?
- What is Molecular Partners AG TTM capital expenditures?
- What is the all time high TTM CAPEX for Molecular Partners AG?
- What is Molecular Partners AG TTM CAPEX year-on-year change?
What is Molecular Partners AG annual capital expenditures?
The current annual CAPEX of MOLN is $899.80 K
What is the all time high annual CAPEX for Molecular Partners AG?
Molecular Partners AG all-time high annual capital expenditures is $1.88 M
What is Molecular Partners AG annual CAPEX year-on-year change?
Over the past year, MOLN annual capital expenditures has changed by -$586.00 K (-39.44%)
What is Molecular Partners AG quarterly capital expenditures?
The current quarterly CAPEX of MOLN is $315.00 K
What is the all time high quarterly CAPEX for Molecular Partners AG?
Molecular Partners AG all-time high quarterly capital expenditures is $669.80 K
What is Molecular Partners AG quarterly CAPEX year-on-year change?
Over the past year, MOLN quarterly capital expenditures has changed by +$131.60 K (+71.76%)
What is Molecular Partners AG TTM capital expenditures?
The current TTM CAPEX of MOLN is $1.01 M
What is the all time high TTM CAPEX for Molecular Partners AG?
Molecular Partners AG all-time high TTM capital expenditures is $1.66 M
What is Molecular Partners AG TTM CAPEX year-on-year change?
Over the past year, MOLN TTM capital expenditures has changed by -$220.10 K (-17.84%)